迈辉国际物流(上海)有限公司
20-99人
公司优势
Mainfreight, a global leader in logistics, provides comprehensive solutions including managed warehousing and both international and domestic freight forwarding. With an extensive network of offices spanning across Australia, China, Europe, New Zealand, and the United States, Mainfreight continues to expand its global reach. The company is listed on the New Zealand Stock Exchange and is steadfast in pursuing its ambitious 100-year vision.
**Historical Development**
Founded in Auckland, New Zealand, in 1979, Mainfreight initially established itself as the nation's leading freight network. In 1984, it strategically expanded its horizons by establishing its first international branch in Mainfreight International. The company's expansion into Australia commenced in 1989, driven by the objective of treating New Zealand and Australia as a unified market. Through a combination of acquisitions and strategic branch openings, Mainfreight significantly enhanced its presence in Australia.
Mainfreight's journey towards globalization took significant strides in 1999 with the acquisition of businesses in Asia and the United States, marking its transition into a truly global player. The full integration of Asian operations was completed in 2007, and today, Mainfreight boasts multiple branches in China. Further expansion into the American market was achieved through the purchase of Target Logistics Services in 2007, enabling Mainfreight USA to provide comprehensive supply chain services across the region.
In 2011, Mainfreight acquired the Wim Bosman Group, significantly augmenting its international network with branches scattered across Europe. This strategic move solidified Mainfreight's position as a global logistics powerhouse.
**Cultivating a Distinctive Culture**
At Mainfreight, the core philosophy "Special people, Special company" encapsulates the essence of its unique corporate culture. This culture has proven successful both domestically in New Zealand and internationally.
Guided by a 100-year vision, Mainfreight makes all decisions considering long-term sustainability and permanence. This perspective influences the company's approach to hiring, training, customer and supplier relationships, growth strategies, and legal and tax structures.
As a customer of a Mainfreight Group company, you can expect:
- An unwavering "anything is possible" mindset
- Assurance of on-time, damage-free delivery of your freight consignments, with prompt and honest resolution of any issues
- Continuous improvement in service through strategic investments in personnel, infrastructure, equipment, and technology
- A nurturing work environment that promotes internal growth, encourages innovation, and fosters a non-hierarchical, decisive outlook among team members
- A sense of family among team members, shared meals, and a strong focus on performance metrics, including regular reporting and transparent key performance indicators linked to employee bonuses
- Rigorous quality management systems, with all branches undergoing internal audits every six months, ensuring consistent excellence in service delivery.
热招职位
相关职位
热门城市
20,861+ 岗位更新等你来订阅
一键订阅最新的岗位,每周送达
🎉恭喜你,订阅成功
继续订阅您可以在邮箱中随时取消订阅
鱼台县传仓日用百货经营店(个体工商户),公司规模少于50人,公司类型民营公司,所属行业影视/媒体/艺术/文化传播。
四季餐厅创立于1992年,始终秉持诚信、乐观、健康、向上的企业精神及传承、经典、健康、时尚、微创、好吃不贵的产品理念。团队汇聚世界名厨5人,具备国家特级厨师资格者30余人,省市一二级厨师和服务师60余人。曾荣获“国家特级酒店”“诚信经营单位”“天津餐饮先进单位”“京津翼餐饮品牌30强”等荣誉,并多次在国内外养生美食大赛中取得佳绩。产品以四季自创菜、融合菜、传统菜、海河两鲜、中西结合为主,在原材料选择上坚持健康优先,菜品制作推崇低糖、低油、低盐,确保无味精、无色素、无食品添加剂,致力于打造食品良心工程。餐厅环境营造醉•美图书馆风格,将图书馆文化与鲜花绿植巧妙融合。服务上坚持以顾客满意度为核心,用心服务每一位顾客,力求让顾客吃得放心、舒心、开心。
诺泰生物(股票代码:688076)是一家专注于多肽药物和小分子化药自主研发与定制研发生产相结合(CDMO)的生物医药企业,于2021年5月在上交所科创板上市。公司业务涵盖了高级医药中间体、原料药到制剂的各个领域。
公司汇聚了一支由中科院上海有机所专家领导,以留美博士为核心的研发团队,拥有3个省级研发中心、5个核心技术平台以及1个诺奖工作站。截至2021年6月,公司已累计获得国家授权专利83项,员工总数超过千人,其中研发人员占比17.36%,研发投入占营业收入的10.74%,处于同行业较高水平。
公司目前拥有1个药物研究院和2个生产基地:
- 杭州市:公司总部兼药物研究院
- 建德市(杭州):CDMO高级医药中间体、原料药生产基地
- 连云港市:多肽及小分子制剂、原料药生产基地
截至2021年6月,公司的研发优势包括:
- CDMO:每年服务30多项创新药研发项目,累计服务200多项,与Incyte、Gilead、Boehringer Ingelheim、Vertex等多家知名制药公司建立了合作关系。
- 制剂产品:已布局7种制剂产品,涵盖利拉鲁肽、索马鲁肽、磷酸奥司他韦、氟维司群等,目前已有3个制剂产品获得注册批件。
- 原料药品种:8个原料药品种获得美国FDA登记,是取得美国FDA、DMF编号并通过完整性审核品种较多的厂家之一。
- 多肽药物:多个长链修饰多肽药物,单批次产量超过5公斤,达到行业先进水平。
经过多年发展,诺泰生物凭借技术、产品和市场的积累,逐步实现技术成果向产业化的转化。研发、新产品注册申报及销售等方面均取得了显著进展,公司正步入快速发展阶段,诚邀各界人士加入!
公司主要从事医疗器械设备的批发和零售业务。
东莞市磅诚电子材料有限公司成立于2017年1月10日,地址在广东省东莞市清溪镇清溪清凤路217号3号楼302室,属于制造业。公司涉及电子、半导体和集成电路领域,员工规模为1-49人。

